NanoVation Therapeutics™’s Post

CRS 2024 Annual Meeting Highlights    Last week, the Controlled Release Society (CRS) awarded our CEO, Dominik Witzigmann, PhD, the 2024 CRS Senior Investigator Award. He also delivered an insightful talk on "Gene Delivery and Gene Editing."   Special thanks to Amanda Bray, Tara Locantore, and colleagues for bringing together these brilliant minds. We also extend our gratitude to AstraZeneca for co-sponsoring the Workshop on "Therapeutic Genome Editing."   Looking forward to the 2025 CRS Annual Meeting in Philadelphia!   #CRS2024 #Biotech #Innovation #LNP #GeneDelivery #GeneEditing #RNA #NanoVationTherapeutics

To view or add a comment, sign in

Explore topics